Home>Repositioning of clinically approved drug Bazi Bushen capsule for treatment of Aizheimer’s disease using network pharmacology approach and in vitro experimental validation
Repositioning of clinically approved drug Bazi Bushen capsule for treatment of Aizheimer’s disease using network pharmacology approach and in vitro experimental validation
- Impact factors: 4
- Publication: Heliyon
- Author:Tongxing Wang, Meng Chen, Huixin Li, Guoyuan Ding, Yanfei Song, Bin Hou, Bing Yao, Zhixin Wang, Yunlong Hou, Junqing Liang, Cong Wei, Zhenhua Jia
- DOI citation-doi:10.1016/j.heliyon.2023.e17603
- Date:2023-06-27